Barcoded DNA Transposition for Contiguity-Preserving Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing nucleic acid sequencing methods face challenges in maintaining contiguity and efficiently determining phasing and methylation status of target nucleic acid sequences, particularly in complex samples like formalin fixed paraffin embedded (FFPE) samples and cell-free DNA.

Innovation Solution

The use of transposome complexes with transferred and non-transferred strands, combined with solid supports having immobilized oligonucleotides with unique barcode sequences, allows for the fragmentation and tagging of nucleic acids while preserving contiguity, enabling simultaneous determination of phasing and methylation status without additional purification steps.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If nucleic acid is fragmented for sequencing, then sequencing efficiency is improved, but contiguity information is lost

Engineering Contradiction:
Improvesequencing efficiencyVSAvoidcontiguity information
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The nucleic acid is divided into multiple fragments through transposition, with each fragment receiving a barcode tag. This segmentation enables parallel processing of multiple fragments while the barcode preserves the original contiguity relationship, allowing reconstruction of the full sequence from fragmented data.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

A barcode sequence acts as an intermediary between the fragmented nucleic acid pieces and the contiguity information. The barcode is attached to each fragment and serves as a identifier that links fragments back to their original position in the parent molecule, enabling reconstruction without physical continuity.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If multiple purification steps are performed to remove transposases and other components, then sequencing quality is improved, but processing time and complexity increase

Engineering Contradiction:
Improvesequencing qualityVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The transposase enzyme is extracted and removed from the reaction mixture after the transposition reaction is complete. This extraction eliminates the need for complex purification steps to remove active enzymes that could interfere with downstream sequencing operations, reducing both time and complexity while maintaining sequencing quality.

Inventive Principle:
Principle #2Taking out (Extraction)

3Loss of information

If transposome complexes are used for fragmentation and tagging, then contiguity preservation is improved, but device complexity increases

Engineering Contradiction:
Improvecontiguity preservationVSAvoidtransposome complex structure
Core Design Contradiction:
Loss of informationVSDevice complexity

Solution Approach 1:

Multiple functions are merged into the transposome complex: fragmentation of nucleic acid, attachment of barcode tags, and preservation of contiguity information all occur in a single integrated reaction step. This combining of functions reduces the need for multiple separate operations and simplifies the overall workflow despite the complexity of the individual transposome structure.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach maintains contiguity and provides efficient sequencing data, particularly in challenging samples, enhancing the detection of genomic variants and methylation patterns without the need for additional purification steps.

Implementation Method 1

at least one of the transposons of the transposome complex comprises an adaptor sequence capable of hybridizing to a complementary capture sequence

Methodology Applied
Scientific EffectHybridization:

Data Source

PatentUS12570971B2Contiguity preserving transposition
Publication Date: 2026.03.10 ILLUMINA CAMBRIDGE LTD
  • US12570971B2 patent drawing
  • US12570971B2 patent drawing
  • US12570971B2 patent drawing

AI summary

Embodiments provided herein relate to methods and compositions for preparing an immobilized library of barcoded DNA fragments of a target nucleic acid, identifying genomic variants, determining the contiguity information, phasing information, and methylation status of the target nucleic acid.